Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

CVS Health Corp
NYSE:CVS
$75.39

Financials

Curr Year EPS Estimate6.37
Next Quarter EPS Estimate1.44
Profit Margin1.17%
Operating Margin3.01
Return on Assets0.02
Return on Equity0.06
Revenue386.5B
Earnings Per Share3.57
Revenue Per Share304.54
Gross Profit51,134,001,152
Quarterly Revenue Growth0.08

General

NameCVS Health Corp
TickerCVS
ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees219,000

About CVS Health Corp

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Dividend

CVS Health Corp pays out a dividend of $2.64 per share, with a dividend yield of 3.50%.

CVS's next dividend payment will be made to shareholders on November 3, 2025.

They pay out 72.76% of their earnings out as a dividend.

Recent Dividends

Nov 3, 2025$0.67
Aug 1, 2025$0.67
May 1, 2025$0.67
Feb 3, 2025$0.67
Nov 1, 2024$0.67
Aug 1, 2024$0.67
May 1, 2024$0.67
Feb 1, 2024$0.67
Nov 1, 2023$0.61
Popular

Lockheed Martin Counters Boeing's F-47 Victory With Cost-Effective F-35 Upgrade Using Sixth-Gen Technology

Lockheed Martin is countering Boeing's F-47 win with a cost-effective F-35 upgrade that integrates sixth-generation tech, aiming to offer 80% of the F-47's capabilities at half the price.

UNHCR official warns that the 1951 refugee convention is increasingly under threat

The U.N. refugee agency said Wednesday that governments around the world, especially in the Global North, and , are increasingly undermining the global convention on refugees and asylum-seekers — even threatening its very existence.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Intel, Fedex, Lennar, Brera Holdings And Rivian: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,142.42. The S&P 500 advanced 0.5% to 6,631.96, while the Nasdaq climbed nearly 1% to 22,470.73.These are the top stocks that gained the attention of retail traders and investors through the day:

Senate approves White House economist Stephen Miran to serve on Federal Reserve board

WASHINGTON (AP) — The Senate has approved one of President Donald Trump’s top economic advisers for a seat on the Federal Reserve’s governing board, giving the White House greater influence over the central bank just two days before of reducing its key interest rate.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Greece's tax revolution harnesses big data and drones to shake off a legacy of crisis

ATHENS, Greece (AP) — With a pristine white exterior, the tax authority's new headquarters looks out of place on a clogged industrial artery outside Athens. A former shopping mall and ice rink, the building has been overhauled into an ultramodern digital center that has led the .

Cadillac F1 team announces multi-year partnership with Jim Beam

The new Cadillac F1 team on Wednesday announced a multi-year that makes the American bourbon distiller its official spirits partner.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

What to know about Brendan Carr, the head of the Federal Communications Commission

WASHINGTON (AP) — ABC took comic Jimmy Kimmel's off the air indefinitely Wednesday, just hours after Federal Communications Commission chairman Brendan Carr called his comments about Charlie Kirk's assassination “truly sick.”

The late Italian fashion designer Giorgio Armani instructs heirs to sell 15% of his empire

MILAN (AP) — After a lifetime of spurning would-be business suitors, the late Italian designer instructed his heirs to sell a 15% minority stake in his vast fashion empire, with priority to the French conglomerate LVMH, the eyewear giant Essilor-Luxottica or the cosmetics company L’Oreal.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

ExxonMobil Sees EU Locking In US LNG Supply Under $750 Billion Pledge

ExxonMobil expects EU to sign long-term LNG contracts worth $750B by 2028. Company urges Europe to embrace contracts despite climate goals.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

US Farmers Head To China As Trade Strains Weigh: Report

U.S. farmers plan a November mission to China, seeking to revive agricultural trade as tensions strain commodity flows.

Oracle's Big AI Bet Faces Credit Risk, Rating Agency Warns

Oracle (NYSE: ORCL) stock rises as AI deals boost investor confidence. However, Moody's warns of risks in $300B AI contracts with OpenAI.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

MediaTek Adopts Taiwan Semiconductor 2nm Breakthrough For Flagship Chip

MediaTek partners with TSMC to develop a flagship SoC using the new 2nm process, a major leap for both companies.

Kimmel's suspension is the latest display of Trump's growing power over the US media landscape

WASHINGTON (AP) — has used threats, lawsuits and government pressure as he remakes the American media landscape, unleashing his long-standing grievances against an industry that has mocked, criticized and scorned him for years.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Trump's Firing Fed Governor Lisa Cook 'For Cause' Not Subject To 'Judicial Second-Guessing,' Says The DOJ Ahead Of FOMC Meeting

Ahead of the Federal Reserve's key vote on interest rates this week, the Justice Department has made a fresh attempt to stay a lower court's injunction blocking President Donald Trump's firing of Fed Governor Lisa Cook.

Uber App To Feature Blade Air Mobility Services In Joby's Next Big Step

Joby Aviation (JOBY) partners with Uber (UBER) to integrate Blade flights into Uber app in 2026.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Hong Kong leader unveils plans to boost economy and nurture emerging industries beyond finance

HONG KONG (AP) — Hong Kong's leader announced plans Wednesday to speed up development of an economic powerhouse near its border with mainland China and nurture industries ranging from artificial intelligence to higher education as the city seeks new economic growth engines to maintain its international competitiveness.

The White House says it blocked US Steel's decision to stop processing steel at Illinois plant

HARRISBURG, Pa. (AP) — The White House said Monday that it intervened under the terms of a three-month-old national security agreement with Japan-based Nippon Steel to block a decision to stop processing raw steel at U.S. Steel's Granite City Works plant in Illinois.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Elon Musk And Sam Altman May Not Agree On Everything, But On This One Topic Their Ideas Align

OpenAI CEO Sam Altman sparked debate by saying society was "better off with phone call culture," echoing other tech leaders and research showing most meetings kill productivity.

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Cyberattack disrupts check-in systems at major European airports

BRUSSELS (AP) — A cyberattack targeting check-in and boarding systems disrupted air traffic and caused delays at several of Europe’s major airports on Saturday, officials said, though the initial impact appeared to be limited.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Scott Bessent Heads To Madrid For High-Stakes Talks With China As TikTok Deadline Looms, Tariff Pressures Escalate

U.S. Treasury Secretary Scott Bessent will meet Chinese Vice Premier He Lifeng in Madrid next week for high-stakes talks on tariffs, agriculture and TikTok's looming U.S. divestment deadline, as trade tensions deepen with Chinese exports to the U.S. plunging 33%.

How Ride-Hailing Platforms Could Be The Real Winners Of The Autonomous Driving Push

Self-driving trend could benefit ride-hailing platforms like Uber & Lyft due to cost advantage & increased safety.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson

Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service